Physician profile
Ryan Anderson
NPI 1578969929
$799.33
in general payments reported to CMS, 2019-2025
12 companies · $532 in 2025
The $532 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $170 · 2024: $97.61 · 2025: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $799.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $149.72 | 2024-2025 | Iovera, Zilretta, Exparel |
| Abbvie INC. | $131.70 | 2025 | |
| Bioventus LLC | $130.20 | 2023 | Durolane |
| Ucb, INC. | $120.26 | 2025 | Bimzelx |
| Tonix Medicines, INC. | $77.10 | 2025 | |
| Amgen INC. | $46.54 | 2025 | Krystexxa |
| Medical Device Business Services, INC. | $39.98 | 2023 | Attune |
| Astrazeneca Pharmaceuticals LP | $23.53 | 2025 | |
| Curonix LLC | $21.99 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Lilly USA, LLC | $20.68 | 2025 | Taltz |
| Janssen Biotech, INC. | $19.12 | 2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $18.51 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.